Search
Now showing items 31-37 of 37
Prescription drugs misuse in “clubbers” and disco goers in Ibiza
(2020-12-15)
Background: Prescription drugs misuse and its related risks are considered a worldwide public health issue. Current trends show that the extent of such phenomenon may not be limited to subjects with psychiatric disorders, ...
Learning to Deal with Problematic Usage of the Internet
(COST action CA16907 and ICOCS (the International College of Obsessive Compulsive Spectrum Disorders), 2020-10-22)
An easily accessible guide for patients, caregivers, family members, and health care professionals presenting a state of the art overview of Problematic Use of the Internet. Ever since its development in the early 1990’s, ...
Club Drugs: Psychotropic Effects and Psychopathological Characteristics of a Sample of Inpatients
(2020-08-31)
Background: growing evidence supports the possibility of significant psychiatric consequences related to novel and traditional psychoactive substance consumption. The problem of differential diagnosis has hampered research ...
Preventing problematic internet use during the COVID-19 pandemic: Consensus guidance
(2020-07)
As a response to the COVID-19 pandemic, many governments have introduced steps such as spatial distancing and "staying at home" to curb its spread and impact. The fear resulting from the disease, the 'lockdown' situation, ...
Substance Related Exogenous Psychosis: a post-modern syndrome
(2020-06-25)
The past two decades have been marked by dramatic social changes, widely characterized by the term “postmodern”. These major transformations have had profound and complex implications for psychiatry, influencing mental ...
Is Cyberchondria a New Transdiagnostic Digital Compulsive Syndrome? A Systematic Review of the Evidence
(2020-05)
Background. Cyberchondria (CYB) has been described relatively recently as a behaviour characterized by excessive online searching for medical information that is associated with increasing levels of health anxiety. Although ...
How deaths can help clinicians and policy-makers understand the risks of Novel Psychoactive Substances.
(2020-01-14)
Novel psychoactive substances (NPS), especially those newly created, are largely an unknown quantity, particularly in terms of their potential serious adverse effects. This means that policy-makers and clinicians are ...